Body imaging, utilizing different imaging modalities, including CT, PET-CT, ultrasound and MRI to evaluate the response of a variety of cancers to treatment. Early, effective evaluation of tumor response can lead to earlier modification of treatment and subsequent implementation of more effective regimens.
Incorporating degree of tracer uptake on PET-CT into RECIST criteria for evaluating tumor response to therapy rather than just measuring change in tumor size after treatment.